Navigation Links
Data To Be Presented at ASCO Supports Potential of Peregrine's Cotara(R) for the Treatment of Brain Cancer
Date:5/31/2008

reatment of recurrent glioblastoma multiforme (GBM)." Sunday, June 1, 2008 2:00 PM - 6:00 PM CDT.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that dose-limiting toxicities may be experienced in future stages of the trial which will use higher doses of Cotara. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the early stage of product development; the significant costs to develop our products as all of our products are currently in development, preclinical studies or clinical
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
2. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
4. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
5. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
6. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
8. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
9. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
10. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
11. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , COVINA, Calif., Nov. 30 S...ommercialization agreement with Academia Sinica, t...rietary methods and Intellectual Property (IP) rel...cells. This method and IP was pioneered by a team... Academia Sinica. Professor Lin is currently the ...
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswire/...the completion of a Phase I study of CPSI-2364, it...roduction of TNF-alpha and other pro-inflammatory ... dose escalation study in healthy volunteers confi... testing. ,, All 30 enrolled subjects complet...
(Date:11/30/2009)... , WALTHAM, Mass., Nov. 30 /PRNewswire/ ...he global authority on medical technology market i... injectable market declined by almost 5% over 2008... a result of the economic crisis. The market will,...l return to the strong pre-recession growth rates ...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 1PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 2
...s is one of a few institutions in the world to off...ch 12 Aurora St. Luke,s Medical Center is one o...ew skin cancer research study that trains the pati...go: http://www.newscom.com/cgi-bin/prnh/20090303/...Lymphocyte (Y-TIL) trial is a phase 2 clinical tri...
...) Evidence Report Compares Effectiveness of CT Col...., March 12 The value of CT colonography, also ...icare considers halting coverage of these procedur... cancer and precancerous growths. Research finding...uggest that CT colonography appears most promising...
Other Medicine Technology:New Hope to Beat Cancer 2Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed 2Virtual Colonoscopies Show Value for Some Patients, But Polyps Will Be Missed 3
(Date:11/30/2009)..., CHICAGO, Nov. 30 Physicians a...ported today on results of a study demonstrating t... angiography (cCTA) by Rcadia,s COR Analyzer Syste...rtery stenosis in hospital emergency department (E...utomated system to enhance the use of cCTA has pot...
(Date:11/30/2009)....S. Centers for Disease Control and Prevention est...ted States are infected with HIV/AIDS. New researc...many of those infected are minorities and do not h...a national strategy to facilitate education and pr...tions. , The research, which analyzed 90,000 HIV...
(Date:11/30/2009)..., NY When asked to inhibit their response to a "c...n average, able to suppress activity in brain regi...dy at the U.S. Department of Energy,s Brookhaven N...n an upcoming issue of NeuroImage , suggest that ...e inhibitory responses could help cocaine abusers ...
(Date:11/30/2009)... extra helpings of gravy and dessert at the holida...than previously thought. According to a new resear...Journal ( http://www.fasebj.org ), a diet that is...es that ultimately cause our bodies to store too m...ble-whammy as the already difficult task of conver...
(Date:11/30/2009)...lcoholics tend to drink heavily more often than yo...Nov. 30 (HealthDay News) -- Older people who are p...unger counterparts, a new report finds, possibly b...effect. , According to a study released this m...an 60 consume more than 40 drinks a week, on avera...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Research highlights need for national HIV strategy 2Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Western diets turn on fat genes 2Health News:Binge Drinking Not Just a Rite of the Young 2
... and effective vaginal contraceptives are urgently...crobial and antiviral properties; as such, they co.../ transmitted diseases (STDs), particularly the hu...not provide any protection against STDs and that t...
...odontal or gum disease may be worse for women in c...dy to be published in The Journal of Maxillofacial...sease, specifically around the wisdom tooth may be... the women were 26 weeks pregnant. The researchers...
...mbulatory medical unit has been set up in Pakistan... to victims of the devastating earthquake. Th... comprises of a total of 52 German doctors and oth... facility has proved to be a boon to the victims o...
...w study that will appear in the next issue of the ... of dental instruments like endodontic files is no...usually employed in general dental practice are us...lected from 25 general dental practices in the UK ...
...York, Oct 11 A common brain test by using EEG ca...n future according to a recent research reported ...hool of Medicine.// Leslie S. Prichep conduc... dementia. Dementia is a brain disorder that ...
...a heikela, Leader of Finpro’s global industry team...two important potential areas of cooperation betwe...thering of Industry representatives at an interact...ostly to other European nations. As part of the Ta...
Other Medicine News:Health News:Dermaseptins: Potent vaginal contraceptives 2
Shutt® Small Joint Graspers
... The HUNTER Active & Passive Tendon Implants are i...cedure developed by Dr. James M. Hunter for the re...ividuals having significant hand tendon injury.The... order to encourage the formation of pseudosynovia...
Swanson Titanium Basal Thumb Implants
PIP Pyrocarbon Total Joint
Medicine Products: